CSL shares rebound after hitting an 8-year low as brokers see a potential upside. The post Why CSL shares are rebounding today after falling to an 8-year low appeared first on The Motley Fool ...
With pressure piling on for CSL, the Australian vaccine and plasma specialist has elected to part ways with its CEO on the eve of its latest earnings announcement. Paul McKenzie, Ph.D., who’s served ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results